An Update on the Diagnosis and Management Options of Glaucoma
Glaucoma remains one of the major causes of blindness worldwide, while a substantial proportion of cases is undiagnosed, especially in the developing world. Early diagnosis and appropriate treatment is of paramount importance to prevent visual loss and maintain quality of life for patients. Substantial improvements in diagnostic tools, new medications along with sustained delivery devices, and novel surgical approaches are promising tools in the effort to limit the burden of the disease to patients and the society. Medical treatment in the form of daily administered eyedrops is still in most instances the first line of treatment. However, poor adherence and side effects significantly influence the efficacy of this approach. Alternative approaches in the form of laser treatments or implantation of sustained delivery devices may overcome the obstacle of poor adherence and have been proven to be beneficial for some categories of the disease. Furthermore, surgical options that are less invasive and therefore safer have emerged to bridge the gap between medical/laser treatment and traditional filtration surgery, which is certainly effective but associated with complications and is therefore reserved for more advanced disease.
The aim of this topic is through incorporating several articles pertinent to the diagnosis and treatment of glaucoma to update the readers regarding the several diagnostic tools that have been added to our armamentarium and the newer treatment options that are at our disposal. The scope of this Special Issue is not limited only to review articles. Papers that address a single diagnostic tool or therapeutic intervention are welcome as long as the discussion part of the paper provides a comprehensive overview of similar modalities and explains where these fit in the diagnostic or therapeutic algorithm.
Dr. Stylianos Kandarakis
Dr. Eythimios Karmiris
Dr. Sotiria Palioura
Dr. Theodoros Filippopoulos
- standard automated perimetry
- medical treatment
- minimally invasive glaucoma surgery
- laser treatment
- angle closure glaucoma open angle glaucoma
- optical coherence tomography
- selective laser trabeculoplasty
- laser peripheral iridotomy
- intraocular pressure
|Journal Name||Impact Factor||CiteScore||Launched Year||First Decision (median)||APC|
|4.757||3.0||2013||17.4 Days||2200 CHF||Submit|
Journal of Clinical & Translational Ophthalmologyjcto
|-||-||2023||15.0 days *||1000 CHF||Submit|
Journal of Clinical Medicinejcm
|4.964||4.4||2012||18 Days||2600 CHF||Submit|
|2.948||2.7||1920||21.9 Days||1800 CHF||Submit|
International Journal of Environmental Research and Public Healthijerph
|-||4.5||2004||20.1 Days||2500 CHF||Submit|
* Median value for all MDPI journals in the second half of 2022.
Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. MDPI journals allow posting on preprint servers such as Preprints.org prior to publication. For more details about reprints, please visit https://www.preprints.org.